COVID-19 Monoclonal Antibodies: Feasible Mechanisms for Generating Needed Evidence

Feasible Mechanisms for Generating Needed Evidence Cover

COVID-19 Monoclonal Antibodies: Feasible Mechanisms for Generating Needed Evidence

Published date

December 10, 2020

Duke-Margolis Affiliated Authors

Morgan Romine headshot

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty